Variant report
Variant | esv1803164 |
---|---|
Chromosome Location | chr19:39768216-39775241 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:39773610..39775882-chr19:39798355..39800719,2 | K562 | blood: | |
2 | chr19:39772630..39774259-chr19:39774538..39776448,2 | K562 | blood: | |
3 | chr19:39772630..39774259-chr19:39774538..39776448,2 | K562 | blood: | |
4 | chr19:39766722..39768435-chr19:39797064..39798738,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11665818 | chr19:39768216-39768217 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs541541187 | chr19:39768259-39768260 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs73050471 | chr19:39768303-39768304 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs140319072 | chr19:39768304-39768305 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs67914309 | chr19:39768358-39768359 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs367898027 | chr19:39768369-39768370 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370461925 | chr19:39768377-39768378 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs553499034 | chr19:39768402-39768403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs146977194 | chr19:39768403-39768404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542459880 | chr19:39768421-39768422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs557376750 | chr19:39768474-39768475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs576045970 | chr19:39768509-39768510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs78743993 | chr19:39768565-39768566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147649949 | chr19:39768577-39768578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs60885838 | chr19:39768602-39768603 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs531291842 | chr19:39768628-39768629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs184262868 | chr19:39768655-39768656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs61535148 | chr19:39768687-39768688 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs142262931 | chr19:39768700-39768701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs549502372 | chr19:39768745-39768746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs568096303 | chr19:39768758-39768759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21364760 | CNVD |
Invasive pancreatic ductal carcinoma | 18765526 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Mental retardation | 19951919 | CNVD |
19q13.11 deletion syndrome | 22378287 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Lung cancer | 21569311 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21509527 | CNVD |
Gastric cancer | 18160780 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:39767600-39768800 | Enhancers | Stomach Mucosa | stomach |
2 | chr19:39768000-39768400 | Enhancers | Liver | Liver |
3 | chr19:39768000-39768400 | Enhancers | Fetal Intestine Small | intestine |
4 | chr19:39768000-39768400 | Enhancers | HepG2 | liver |
5 | chr19:39768000-39768800 | Enhancers | Placenta | Placenta |
6 | chr19:39768200-39768400 | Bivalent Enhancer | A549 | lung |
7 | chr19:39768400-39768600 | Enhancers | A549 | lung |